Skip to main content

Correction to: Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy

Correction to: Molecular Cancer (2020) 19: 19

https://doi.org/10.1186/s12943-020-1144-6

After publication of the article [1], authors found out that Fig. 1 was inadvertently replaced. Correct Fig. 1 version is provided on this paper.

Fig. 1
figure1

Summary of biomarkers of the response to anti-PD-1/PD-L1 immunotherapy

Reference

  1. 1.

    Ren D, Hua Y, Yu B, Ye X, He Z, Li C, Wang J, Mo Y, Wei X, Chen Y, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Zeng Z, Xiong W. Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy. Mol Cancer. 2020. https://doi.org/10.1186/s12943-020-1144-6.

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Wei Xiong.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ren, D., Hua, Y., Yu, B. et al. Correction to: Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy. Mol Cancer 19, 31 (2020). https://doi.org/10.1186/s12943-020-01148-y

Download citation